Approval · Notice of Compliance 4509 · 1996
PRINIVIL: Notice of Compliance 4509
Issued November 12, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4509
- Date
- November 12, 1996
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New indication: treatment of hypertension and congestive heart failure
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRINIVIL | Not yet assigned | — |
Medicinal ingredients
- LISINOPRIL 5 MG per TAB
- LISINOPRIL 10 MG per TAB
- LISINOPRIL 20 MG per TAB
- LISINOPRIL 40 MG per TAB
- LISINOPRIL 80 MG per TAB